Immune responsiveness of a novel peptidoglycan conjugate prepared from surface Candida immunogens: Mannan and CR3-related protein

FEMS Immunology and Medical Microbiology

Volumn 53, Issue 3, 2008, Pages 421-428

  Paulovičová, Ema ^a   Bystrický, Slavomír ^a   Machová, Eva ^a   Bujdáková, Helena ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

Candida; Candidal CR3 related protein; Glycoconjugate; Mannan; Vaccine

Indexed keywords

FUNGUS ANTIGEN; GLYCOCONJUGATE; INTERLEUKIN 2 RECEPTOR ALPHA; MANNAN; MANNAN COMPLEMENT RECEPTOR TYPE 3 RELATED PROTEIN CONJUGATE; PEPTIDOGLYCAN; VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CANDIDA ALBICANS; CELLULAR IMMUNITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; B-LYMPHOCYTES; CANDIDA ALBICANS; CD4-CD8 RATIO; CELL ADHESION MOLECULES; FEMALE; FUNGAL PROTEINS; FUNGAL VACCINES; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MANNANS; PEPTIDOGLYCAN; RABBITS;

EID: 48449094418     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2008.00442.x     Document Type: Article

References (36)

1. Alaei S, Larcher C, Ebenbichler C, Prodinger WM, Janatova J Dierich MP (1993) Isolation and biochemical characterization of the iC3b receptor of Candida albicans. Infect Immun 61 : 1395 1399.
2. Alberti-Segui Ch, Morales AJ, Xing H et al 2004) Identification of potential cell-surface proteins in Candida albicans and investigation of the role of a putative cell-surface glycosidase in adhesion and virulence. Yeast 21 : 285 302.
3. Brisslert M, Bokarewa M, Larsson P, Wing K, Collins LV Tarkowski A (2006) Phenotypic and functional characterization of human CD25+ B cells. Immunology 117 : 548 557.
4. Bromuro C, Torosantucci A, Chiani P, Conti S, Polonelli L Cassone A (2002) Interplay between protective and inhibitory anti-bodies dictates the outcome of experimentally disseminated candidiasis in recipients of Candida albicans vaccine. Infect Immun 70 : 5462 5470.
5. Bujdakova H, Wurzner R, Klobusicky M Dierich MP (1997) Expression and quantification of the IC3b-binding protein in different Candida albicans strains and their morphological stages. FEMS Immunol Med Microbiol 18 : 147 152.
6. Bujdáková H, Paulovičová E, Melkusová S, Gašperík J, Machová E Kucharíková S (2006) Purification and characterization of immunologically active Candida albicans surface antigen. 16th Congress of the International Society for Human and Animal Mycology. Paris, France, 25-29 June 2006. Abstract book: Poster abstract No. P-0592.
7. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C Germain RN (2006) Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440 : 890 895.
8. Cutler JE (2005) Defining criteria for anti-mannan antibodies to protect against candidiasis. Curr Mol Med 5 : 383 392.
9. Dagan R, Eskola J, Leclerc C Leroy O (1998) Reduced response to multiple vaccines sharing common protein epitopes that are administrated simultaneously to infants. Infect Immun 66 : 2093 2098.
10. Dimopoulos G, Karabinis A, Samonis G Falagas M (2007) Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study. Eur J Clin Microbiol Infect Dis 26 : 377 384.
11. Dubois M, Gilles KA, Hamilton JK, Rebers PA Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28 : 350 356.
12. Eigentler A, Schulz TF, Larcher C, Breitwieser EM, Myones BL, Petzer AL Dierich MP (1989) C3bi-binding protein on Candida albicans: temperature- dependent expression and relationship to human complement receptor type 3. Infect Immun 57 : 616 622.
13. Faggi E, Pini G, Campisi E, Martinelli C Difonzo E (2005) Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus infected and non-infected patients and in a yeast culture collection. Mycoses 48 : 211 215.
14. Fields R (1971) The measurement of amino groups in proteins and peptides. Biochem J 124 : 581 590.
15. Han Y, Ulrich MA Cutler JE (1999) Candida albicans mannan extract-protein conjugate induce a protective immune response against experimental candidosis. J Infect Dis 179 : 1477 1484.
16. Hostetter MK (1996) An integrin-like protein in Candida albicans: implications for pathogenesis. Trends Microbiol 4 : 242 246.
17. Jeng HW, Holmes AR Cannon RD (2005) Characterization of two Candida albicans surface mannoprotein adhesins that bind immobilized saliva components. Med Mycol 43 : 209 217.
18. Le Cabec V, Carreno S, Moisand A, Bordier C MaridonneauParini I (2002) Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J Immunol 169 : 2003 2009.
19. Lett E, Gangloff S, Zimmermann M, Wachsmann D Klein J-P (1994) Immunogenicity of polysaccharides conjugated to peptides containing T- and B-cell epitopes. Infect Immun 62 : 785 792.
20. Ližičárová I, Matulová M, Machová E Capek P (2007) Cell wall mannan of human pathogen Candida dubliniensis. Carbohydr Polym 68 : 191 195.
21. Mavor AL, Thewes S Hube B (2005) Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr Drug Targets 6 : 863 874.
22. McGeary RP, Olive C Toth I (2003) Lipid and carbohydrate based adjuvant/carriers in immunology. J Peptide Sci 9 : 405 418.
23. Mochon AB Cutler JE (2005) Prospects of vaccines for medically important fungi. Med Mycol 43 : 97 115.
24. Paulovičová E, Bystrický S, Masárová J, Machová E Mislovičová D (2005) Immune response to Saccharomyces cerevisiae mannan conjugate in mice. Int Immunopharmacol 5 : 1693 1698.
25. Paulovičová E, Machová E, Tulinská J Bystrický S (2007) Cell and antibody mediated immunity induced by vaccination with novel Candida dubliniensis mannan immunogenic conjugate. Int Immunopharmacol 7 : 1325 1333.
26. Pfaller MA Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20 : 133 163.
27. Richardson MD (2005) Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56 (suppl 1), i5 i11.
28. Romani L (2004) Immunity to fungal infections. Nat Rev Immunol 4 : 1 13.
29. Ruhnke M (2006) Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets 7 : 495 504.
30. Sahin GO Akova M (2006) Treatment of invasive infections due to rare or emerging yeasts and moulds. Expert Opin Pharmacother 7 : 1181 1190.
31. Sedmak JJ Grossberg SE (1977) A rapid, sensitive and versatile assay for protein using coomassie brilliant blue G250. Anal Biochem 79 : 544 552.
32. Segal E (2005) Candida, still number one - what do we know and where are we going from there. Mycoses 48 (suppl 1), 3 11.
33. Stambas J, Pietersz G, McKenzie I Cheers C (2002) Oxidized mannan as a novel adjuvant inducing mucosal IgA production. Vaccine 20 : 1068 1078.
34. Sullivan DJ, Westerneng TJ, Haynes KA, Bennet DE Coleman DC (1995) Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141 : 1507 1521.
35. Taborda CP Casadewall A (2002) CR3 (CD11b/CD18) and CD4 (CD11c/CD18) are involved in complement-independent antibody mediated phagocytosis of Cryptococcus neoformans. Immunity 16 : 791 802.
36. Zhang MX, Cutler JE, Han Y Kozel TR (1998) Contrasting roles of mannan-specific monoclonal immunoglobulines M antibodies in the activation of classical and alternative pathways by Candida albicans. Infect Immun 66 : 6027 6029.